2017 American Transplant Congress » Concurrent Session: Heart Transplantation: Antibodies and Outcomes

Date: Monday, May 1, 2017

Time: 2:30pm-4:00pm

Location: E271b

Session Type: Concurrent Session

Meeting: 2017 American Transplant Congress

2:30pm-2:42pm: Gene Expression Profiling for the Identification and Classification of Antibody-Mediated Heart Rejection.

A. Loupy,¹ J. Duong Van-Huyen,¹ L. Hidalgo,² J. Reeve,² M. Racapé,¹ O. Aubert,¹ J. Venner,² D. Viglietti,¹ P. Bruneval,¹ C. Lefaucheur,¹ P. Halloran.²

2:42pm-2:54pm: Young African American Heart Transplant Recipients Have an Elevated Risk of Post-Transplant Mortality.

H. Maredia, M. Bowring, A. Massie, S. Oyetunji, C. Merlo, R. Higgins, D. Segev, E. Bush.

2:54pm-3:06pm: Clinical Correlation of Endomyocardial Biopsies Molecular Profiling: Taking Rejection Diagnosis Beyond Histology.

L. Potena,¹ L. Borgese,¹ A. Gaudenzi,¹ V. Agostini,¹ J. Reeve,² M. Masetti,¹ F. Grigioni,¹ O. Leone,¹ P. Halloran.

3:06pm-3:18pm: Validation of a Prediction Model for Cardiac Allograft Vasculopathy.

E. Kransdorf, T. Aintablian, M. Kittleson, J. Patel, J. Kobashigawa.

3:18pm-3:30pm: High Titer De Novo Donor-Specific HLA Alloantibodies and Cardiac Allograft Vasculopathy After Pediatric Heart Transplantation.

B. Das,¹ S. Zhang,² A. Gao,² C. Lacelle.³

3:30pm-3:42pm: Primary Graft Dysfunction After Pediatric Heart Transplant.

K. Mowers, K. Simpson, P. Eghtesady, O. Petrucci, C. Canter, C. Castleberry.

3:42pm-3:54pm: Antibodies to Angiotensin Type II Receptor I Are Associated with Primary Graft Dysfunction After Orthotopic Heart Transplant in Patients with Ventricular Assist Device as Bridge to Transplant.

M. Hickey,¹ E. DePasquale,² S. Shah,³ D. Vucicevic,² J. Zhang,¹ N. Valenzuela,¹ M. Deng,² E. Reed.¹

« View all sessions from the 2017 American Transplant Congress